Investigational. In clinical development, not approved. Material sold as a research chemical is not the trial drug. Educational only — not medical advice.
What it is
Mazdutide is a dual GLP-1 / glucagon receptor agonist in clinical development for diabetes and obesity.
Proposed mechanism
It combines GLP-1 agonism (satiety, glucose control) with glucagon-receptor agonism (energy expenditure) — the same twin-pathway logic behind retatrutide, minus the GIP arm.1
State of the evidence
Phase 3 development, strongest in China; not FDA-approved.
Regulatory & status
Investigational; approval status varies by region.
Reconstitution (reference only)
Lab-handling reference only — not a preparation or dosing instruction: 1 mL (100 units) reconstitution solution per 10 mg vial. See the reconstitution calculator for the arithmetic. This page does not provide dosing guidance.
For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.